Growth Metrics

Beta Bionics (BBNX) Net Cash Flow (2024 - 2026)

Beta Bionics' Net Cash Flow history spans 3 years, with the latest figure at -$1.4 million for Q1 2026.

  • On a quarterly basis, Net Cash Flow fell 111.4% to -$1.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$12.2 million, a 160.09% decrease, with the full-year FY2025 number at $1.1 million, down 70.41% from a year prior.
  • Net Cash Flow hit -$1.4 million in Q1 2026 for Beta Bionics, up from -$6.9 million in the prior quarter.
  • Over the last five years, Net Cash Flow for BBNX hit a ceiling of $13.0 million in Q4 2024 and a floor of -$9.0 million in Q2 2024.
  • Historically, Net Cash Flow has averaged $404444.4 across 3 years, with a median of -$1.4 million in 2026.
  • The widest YoY moves for Net Cash Flow: up 367.51% in 2025, down 153.35% in 2025.
  • Tracing BBNX's Net Cash Flow over 3 years: stood at $13.0 million in 2024, then crashed by 153.35% to -$6.9 million in 2025, then skyrocketed by 80.17% to -$1.4 million in 2026.
  • Business Quant data shows Net Cash Flow for BBNX at -$1.4 million in Q1 2026, -$6.9 million in Q4 2025, and $3.4 million in Q3 2025.